Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.